Über uns
Über uns
Führungsteam
Partnerschaften
Technologie
Technologie
Produktion
Publikationen
Pipeline
Newsroom
News
Events
Downloads
Investor Relations
Überblick
Aktieninformation
Analysten-Coverage
Hauptversammlung 2022
Finanzberichte
Corporate Governance
E-Mail Alert
Karriere
Werden Sie Teil der RNA people
Ausbildung
Aktuelle Stellenangebote
DE
Clinical Data
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
by Sovereign
Intradermal Vaccinations With RNA Coding for TAA Generate CD8(+) and CD4(+) Immune Responses and Induce Clinical Benefit in Vaccinated Patients
by Sovereign
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients
by Sovereign
1
2
